发布日期:2023-10-11 15:08 浏览次数:
名称: | anti- LIF antibody |
---|---|
货号: | FNab09804 |
适应种属: | 人源 |
规格: | 100ug(微克) |
状态: | 液体 |
纯化方法: | 免疫亲和纯化 |
纯度: | 经SDS-PAGE分析,纯度大于95% |
宿主: | 兔 |
亚型: | lgG |
存储: | 用添加了0.02%叠氮化钠和50%甘油的PBS溶解,PH值7.3,可在-20℃下保存12个月(避免反复冻融) |
免疫原: | leukemia inhibitory factor |
免疫原别称: | CDF antibody, D factor antibody, DIA antibody, Emfilermin antibody, HILDA antibody, Leukemia inhibitory factor antibody, LIF antibody, Melanoma derived LPL inhibitor antibody, MLPLI antibody |
分子量: | 22KD |
验证应用: | ELISA, IHC, WB |
建议稀释比例: | WB: 1:200-1:1000; IHC: 1:50-1:500 |
UniProt ID: | P15018 |
克隆性: | 多克隆 |
背景介绍: | LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. |
图像: | Immunohistochemistry of paraffin-embedded human lung cancer tissue slide using FNab09804(LIF Antibody) at dilution of 1:200。 Jurkat cells were subjected to SDS PAGE followed by western blot with FNab09804(LIF Antibody) at dilution of 1:500。 |